Osteoporosis B. pathology and pathophysiology

Primer on the Rheumatic Diseases: Thirteenth Edition

Volumn , Issue , 2008, Pages 584-591

  Sambrook, Philip ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84884811772     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-0-387-68566-3_76     Document Type: Chapter

References (10)

1. Boyle WJ, Scott Simonet W, Lacey DL. Osteoclast differentiation and activation. Nature 2003;423:337-342.
2. Cenci S, Weitzmann MN, Roggia C, et al. Estrogen defi-ciency induces bone loss by enhancing T-cell production of TNF-alpha. J Clin Invest 2000;106:1229-1237.
3. Pfeilschifter J, Koditz R, Pfohl M, Schatz H. Changes in proinflammatory cytokine activity after menopause. Endocr Rev 2002;23:90-119.
4. Currey JD. The mechanical properties of bone. In: Currey JD, ed. Bones: structure and mechanics. 2nd ed. Princeton, NJ: Princeton University Press; 2002:54-122.
5. Naganathan V, MacGregor A, Snieder H, Nguyen T, Spector T, Sambrook PN. Gender differences in the genetic factors responsible for variation in bone density and ultrasound. J Bone Miner Res 2002;17:725-733.
6. Mann V, Hobson EE, Li B, et al. A COL1A1 Sp1 binding site polymorphism predisposes to osteoporotic fracture by affecting bone density and quality. J Clin Invest 2001;107: 899-907.
7. Van Staa TP, Leufkens HGM, Abenhaim L, Zhang B, Cooper C. Use of oral glucocorticoids and risk of fractures. J Bone Miner Res 2000;15:993-1000.
8. Petty S, Paton LM, O'Brien TJ, et al. Effect of antiepilep-tic medication on bone mineral measures. Neurology 2005;65:1358-1365.
9. Gage BF, Birman-Deych E, Radford, MJ, Nilasena, DS, Binder EF. Risk of osteoporotic fracture in elderly patients taking warfarin: results from the national registry of Atrial Fibrillation 2. Arch Intern Med 2006;166:241-246.
10. Eastell R, Hannon R. Long term effects of aromatase inhibitors on bone. J Steroid Biochem Molec Biol 2005; 95:151-154.